Selective beta(3)-adrenoceptor agonists for the treatment of overactive bladder
Chiudendo questo banner, scorrendo questa pagina, cliccando su un link o proseguendo la navigazione in altra maniera, acconsenti alluso dei cookie
Weight loss was primarily from fat mass rather than lean mass, and the treatment was generally well-tolerated with no significant adverse effects on glucose metabolism, insulin levels, or IGF-1 levels
Researchers examine how NNMT inhibition affects NAD+ levels, sirtuin activity, mitochondrial efficiency, glucose/lipid metabolism, and metabolic parameters in experimental systems focused on aging and metabolic disorders
Disclaimer: This product is sold strictly for laboratory research purposes